Oncgnostics
Latest round
- Series A
Last raised
- Jan 2015
Total raised
- $0.8M
Investors
- 3
About Oncgnostics
Oncgnostics GmbH specializes in molecular diagnostics, particularly for cancer.Oncgnostics GmbH specializes in molecular diagnostics for cancer, focusing on innovative tests to enhance early detection and diagnosis. Their flagship product, GynTect®, is a molecular test for cervical cancer available since 2015, utilizing patented biomarkers for improved screening accuracy. This initiative aims to broaden the company's market presence and enhance accessibility of their innovative products.
Who invested in Oncgnostics
3 investors across 2 rounds
See all investors in Oncgnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oncgnostics
Who invested in Oncgnostics?
Oncgnostics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oncgnostics raised?
Oncgnostics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Oncgnostics last raise money?
Oncgnostics's most recent round on record is a Series A, in Jan 2015.
What does Oncgnostics do?
Oncgnostics GmbH specializes in molecular diagnostics, particularly for cancer.
Where is Oncgnostics headquartered?
Oncgnostics is headquartered in Jena, Germany.
Which VCs invest in companies like Oncgnostics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Oncgnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Oncgnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.